Research Studies
Published research on HBOT for Alzheimer's Disease & Cognitive Decline
← Browse all conditions in the PubMed Research LibraryHyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment. (opens PubMed in a new tab)
Chen J; Zhang F; Zhao L; Cheng C; Zhong R; Dong C; Le W — Alzheimer's & dementia (New York, N. Y.)
Plain English Summary
Patients with Alzheimer's disease or amnestic mild cognitive impairment showed some short-term improvements in cognitive scores following HBOT.
Limitations & context: The abstract does not describe a blinded randomized design. Short-term score changes do not establish prevention, cure, or slowed disease progression.
Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer's disease mouse model and in elderly patients. (opens PubMed in a new tab)
Shapira R; Gdalyahu A; Gottfried I; Sasson E; Hadanny A; Efrati S; Blinder P; Ashery U — Aging
Plain English Summary
The investigators studied vascular and amyloid changes in an Alzheimer's mouse model and also reported brain blood-flow and cognitive changes in older people with memory loss.
Limitations & context: Animal findings must not be presented as demonstrated Alzheimer's treatment effects in humans. The human work was exploratory.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.